1)Gnjidic D, et al:Polypharmacy cutoff and outcomes;five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65(9):989-995,2012.
2)Barnett K, et al:Epidemiology of multimorbidity and implications for health care, research, and medical education;a cross-sectional study. Lancet 380(9836):37-43,2012.
3)World Health Orgnaization:Section I Setting the scene, Chapter I Defining Adherence.ADHERENCE TO LONG-TERM THERAPIES;EVIDENCE FOR ACTION. pp17-19, 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/
4)Hanlon JT, et al:A method for assessing drug therapy appropriateness. J Clin Epidemiol 45(10):1045-1051, 1992.
5)Kalisch LM, et al: The prescribing cascade. Aust Prescr 34(6):162-166,2011. http://www.australianprescriber.com/magazine/34/6/issue/161.pdf